Answers are grounded in this paper and cite their sources.
// Xue-Min Wu 1,* , Zhi-Feng Xi 2,* , Pinhu Liao 3,* , Hong-Dong Huang 4,* , Xiao-Ying Huang 1,* , Chao Wang 3,* , Yun Ma 5 , Qiang Xia 2 , Jin-Guang Yao 1 and Xi-Dai Long 1,2 1 Department of Pathology, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China 2 Department of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China 3 Department of Medicine, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China 4 Division of Medicine, Beijing Shijitan Hospital, Capital Medical University, Beijing, China 5 Department of Pathology, The Affiliated Tumor Hospital, Guangxi Medical University, Nanning, China * These authors have contributed equally to the manuscript Correspondence to: Xi-Dai Long, email: // Keywords : microRNA-4651, aflatoxin B1, hepatocellular carcinoma, diagnostic and prognostic biomarkers Received : November 22, 2016 Accepted : February 18, 2017 Published : March 08, 2017 Abstract Background: The serum microRNAs have been reported as potential biomarkers for hepatitis virus-related hepatocellular carcinoma (HCC); however, their role in aflatoxin B1 (AFB1)-related HCC to has not yet been evaluated. Materials and Methods: We conducted a case-control study, including 366 HCC cases and 662 controls without any evidence of tumors, to identify and assess diagnostic and prognostic potential of serum microRNAs for AFB1-related HCC. The sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) were used to elucidate diagnostic performance, and to compare the microRNAs with α-fetoprotein (AFP) at a cutoff of 20 ng/mL (AFP20) and 400 ng/mL (AFP400). Results: We found 8 differentially expressed microRNAs via the microRNA array analysis; however, only microRNA-4651 was further identified to detect AFB1-positive HCC but not AFB1-negative HCC. For AFB1-positive HCC, microRNA-4651 showed higher accuracy and sensitivity than AFP400 (AUC, 0.85 vs . 0.72; Sensitivity, 78.1% vs. 43.0%). Compared to AFP20, microRNA-4651 exhibited higher potential in identifying small-size (0.68 vs. 0.84 for AUC and 36.7% vs . 75.5% for sensitivity, respectively) and early-stage HCC (0.69 vs . 0.84 for AUC and 38.7% vs . 75.7% for sensitivity, respectively). Additionally, miR-4651 was also associated with HCC prognosis (hazard risk value, 2.67 for overall survival and 3.62 for tumor recurrence analysis). Conclusions: These data suggest that serum microRNA-4651 may be a useful marker for HCC diagnosis and prognosis, especially AFB1-positive cases.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: